CORTINOVIS, DIEGO LUIGI
CORTINOVIS, DIEGO LUIGI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Dorsal sural nerve conduction study in the assessment of oxaliplatin induced peripheral neuropathy
2010 Alberti, P; Frigeni, B; Cavaletti, G; Ferrarese, C; Ferrara, R; Piccirilli, C; Resta, G; De Ponti, A; Rotondi, A; Della Vecchia, A; Villa, P; Cortinovis, D; Longarini, L; Acquati, M; Bidoli, P
Major issue in chemotherapy-induced peripheral neuropathy (cipn): lack of standardized measurement scales. ciperinoms study: validity and reliability in cipn assessment
2012 Cortinovis, D; Cazzaniga, M; Cavaletti, G; Giuntini, N; Canova, S; Alberti, P; Bidoli, P; CI Perinoms Study, G
When progressive dysphagia could be related to an “old friend” – a case report
2012 Alberti, P; Fumagalli, L; Piatti, M; Santoro, P; Pettinaroli, R; Cortinovis, D; Cazzaniga, M; Bidoli, P; Ferrarese, C
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose
2012 Alberti, P; Cortinovis, D; Cazzaniga, M; Bidoli, P; Cavaletti, G
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study.
2012 Andreas, A; Alberti, P; Briani, C; Velasco, R; Bruna, J; Campagnolo, M; Cazzaniga, M; Bergamo, F; Cortinovis, D; Santos, C; Papadimitriou, K; Cavaletti, G; Kalofonos, H
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
2012 Argyriou, A; Velasco, R; Briani, C; Cavaletti, G; Bruna, J; Alberti, P; Cacciavillani, M; Lonardi, S; Santos, C; Cortinovis, D; Cazzaniga, M; Kalofonos, H
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study
2013 Argyriou, A; Cavaletti, G; Antonacopoulou, A; Genazzani, A; Briani, C; Bruna, J; Terrazzino, S; Velasco, R; Alberti, P; Campagnolo, M; Lonardi, S; Cortinovis, D; Cazzaniga, M; Santos, C; Psaromyalou, A; Angelopoulou, A; Kalofonos, H
The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy.
2014 Alberti, P; Cacciavillani, M; Bruna, J; Roser, V; Briani, C; Campagnolo, M; Roncaletti, S; Cazzaniga, M; Cortinovis, D; Kalofonos, H; Cavaletti, G; Argyriou, A
Long-term course of oxaliplatin-induced polyneuropathy: a prospective two-year follow-up study
2014 Briani, C; Argyriou, A; Izquierdo, C; Velasco, R; Campagnolo, M; Alberti, P; Frigeni, B; Cacciavillani, M; Bergamo, F; Cortinovis, D; Cazzaniga, M; Bruna, J; Cavaletti, G; Kalofonos, H
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool
2015 Jaconi, M; Pagni, F; Vacirca, F; Leni, D; Corso, R; Cortinovis, D; Bidoli, P; Bono, F; Cuttin, M; Valente, M; Pesci, A; Bedini, V; Leone, B
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis
2015 Terrazzino, S; Argyriou, A; Cargnin, S; Antonacopoulou, A; Briani, C; Bruna, J; Velasco, R; Alberti, P; Campagnolo, M; Lonardi, S; Cortinovis, D; Cazzaniga, M; Santos, C; Kalofonos, H; Canonico, P; Genazzani, A; Cavaletti, G
MR309/E-52862, a first-in-class sigma-1 receptor antagonist, in oxaliplatin-induced peripheral neuropathy. An exploratory Phase II clinical trial
2016 Bruna, J; Videla, S; Argyriou, A; Velasco, R; Villoria, J; Vaqué, ; Nadal, C; Cavaletti, G; Alberti, P; Briani, C; Ortiz, E; Kalofonos, C; Cortinovis, D; Sust, M; Plata Salamán, C
Focus on nivolumab in NSCLC
2016 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
2017 Kieffer, J; Postma, T; van de Poll Franse, L; Mols, F; Heimans, J; Cavaletti, G; Aaronson, N; Cavaletti, G; Cornblath, D; Merkies, I; Postma, T; Valsecchi, M; Galimberti, S; Rossi, E; Cavaletti, G; Frigeni, B; Lanzani, F; Mattavelli, L; Piatti, M; Alberti, P; Binda, D; Bidoli, P; Cazzaniga, M; Cortinovis, D; Bruna, J; Velasco, R; Argyriou, A; Kalofonos, H; Psimaras, D; Ricard, D; Pace, A; Galiã¨, E; Briani, C; Lucchetta, M; Campagnolo, M; Torre, C; Faber, C; Merkies, I; Vanhoutte, E; Bakkers, M; Brouwer, B; Boogerd, M; Lalisang, R; Boogerd, W; Brandsma, D; Koeppen, S; Hense, J; Grant, R; Storey, D; Kerrigan, S; Schenone, A; Reni, L; Piras, B; Fabbri, S; Pessino, A; Padua, L; Granata, G; Leandri, M; Ghignotti, I; Plasmati, R; Pastorelli, F; Postma, T; Heimans, J; Eurelings, M; Meijer, R; Grisold, W; Pozza, E; Mazzeo, A; Toscano, A; Russo, M; Tomasello, C; Altavilla, G; Prado, M; Gonzalez, C; Dorsey, S
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve
2018 Alberti, P; Rossi, E; Argyriou, A; Kalofonos, H; Briani, C; Cacciavillani, M; Campagnolo, M; Bruna, J; Velasco, R; Cazzaniga, M; Cortinovis, D; Valsecchi., M; Cavaletti, G
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib
2019 Sharma, G; Cortinovis, D; Agustoni, F; Arosio, G; Villa, M; Cordani, N; Bidoli, P; Bisson, W; Pagni, F; Piazza, R; Gambacorti-Passerini, C; Mologni, L
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience
2019 Vigliar, E; Malapelle, U; Bono, F; Fusco, N; Cortinovis, D; Valtorta, E; Spyridon, A; Bimbatti, M; Zocchi, M; Piva, C; Gaudioso, G; Iaccarino, A; Morbini, P; Pagni, F
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
2019 Giordano, F; Vaira, V; Cortinovis, D; Bonomo, S; Goedmakers, J; Brena, F; Cialdella, A; Ianzano, L; Forno, I; Cerrito, M; Giovannoni, R; Ferri, G; Tasciotti, E; Vicent, S; Damarco, F; Bosari, S; Lavitrano, M; Grassilli, E
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases
2020 Lagana, M; Gurizzan, C; Roca, E; Cortinovis, D; Signorelli, D; Pagani, F; Bettini, A; Bonomi, L; Rinaldi, S; Berardi, R; Filetti, M; Giusti, R; Pilotto, S; Milella, M; Intagliata, S; Baggi, A; Cortellini, A; Soto Parra, H; Brighenti, M; Petrelli, F; Bennati, C; Bidoli, P; Garassino, M; Berruti, A
ALK determination: Liquid and tissue biopsy. Comparing techniques and effectiveness of alectinib in a controversial clinical case [Determinazione di ALK: Tra biopsia liquida e tissutale. Tecniche a confronto ed efficacia di alectinib in un caso clinico controverso]
2020 Cortinovis, D; Migliorati, F; Pagni, F